HOXB13 and neoplasm: In ER-positive patients treated with tamoxifen, the risk for breast cancer death was positively associated with HOXB13:IL17BR, MGI, MGI+HOXB13:IL17BR, and BCI in models without tumor size and tumor grade (Table 3).